Don’t let Omicron fool you.
Now is the time to layer protection:
– Get your first, second, or third shot
– Wear a well fitted mask
– Ventilate your spaces ️
– Limit gatherings
Share our original Tweet!
Thanks to committed scientists around the world, we have learned a lot about #Omicron.
Here’s what we know* now; the good news and the bad news.
*A lot of this research is still pre-print – things may change
[1/10]#ScienceUpFirst pic.twitter.com/NUud2ndtun
— ScienceUpFirst | LaScienced’Abord (@ScienceUpFirst) January 12, 2022
View our original Instagram Post!
View this post on Instagram
Sources
- Understanding omicron’s many mutations
- SARS-CoV-2 Omicron VOC Transmission in Danish Households
- Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
- Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021
- HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung
- Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
- Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa
- The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
- SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
- Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave
- COVID-19 daily epidemiology update
- Coronavirus: What’s happening in Canada and around the world on Jan. 9
- New Admissions of Patients with Confirmed COVID-19 per 100,000 Population by Age Group, United States
- Why COVID-19 hospitalizations of Canadian kids — and infants — could keep rising as Omicron spreads
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
- Current COVID-19 Risk in Ontario by Vaccination Status
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
